In Brief: Organic Guidance; NAD Review; FTC Enforcement; FDA Warning

USDA organic guidance; NAD challenges Akeso’s “doctor recommended” claims; new name for NCCAM proposed; FTC finalizes decree with GeneLink; Fortune Hi-Tech Marketing resolves pyramid allegations; CDJ supplements are unapproved new drugs; more news In Brief.